Belize vs Vanuatu: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Belize
75.0%
in 2025
Vanuatu
76.0%
in 2025
Belize rank
130th
Vanuatu rank
128th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Belize
- Vanuatu
How they compare
Vanuatu currently reports 76.0% against 75.0% in Belize, a difference of 1.0%.
Across all 18 years both countries report, Vanuatu has been ahead every year.
Belize ranks 130th and Vanuatu ranks 128th of 194 countries.
Vanuatu has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 19.0% | 49.0% | 30.0% | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Belize or Vanuatu?
- Vanuatu, at 76.0% against 75.0% in Belize as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Belize and Vanuatu?
- 1.0%, with Vanuatu ahead.
- How many years of comparable data are there for Belize and Vanuatu?
- 18 years are reported by both, from 2008 to 2025.
- How do Belize and Vanuatu rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Belize ranks 130th and Vanuatu ranks 128th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.